The New Political Economy of Pharmaceuticals [electronic resource] : Production, Innovation and TRIPS in the Global South /
Löfgren, Hans.editor.
Williams, Owain David.editor.
Some two decades will shortly have passed since the WTO's Trade Related Aspects of Intellectual Property Rights agreement came into force in 1995. This volume is the first cross-country analysis of how TRIPS has affected the capacity of 11 major low or medium income countries to produce generic drugs.
Bibliographic Level Mode of Issuance: Monograph
Includes bibliographical references and index.
Machine generated contents note: -- 1. The New Political Economy of Pharmaceuticals: Conformity and Resistance in the Global South; Owain David Williams and Hans Löfgren -- 2. The Political Economy of Pharmaceutical Production in Brazil; Cassandra M. Sweet -- 3. Pharmaceuticals, Health Policy and Intellectual Property Rights in China; Chee-Ruey Hsieh -- 4. Immunity to TRIPS? Vaccine Production and the Biotechnology Industry in Cuba; Jens Plahte and Simon Reid-Henry -- 5. TRIPS and Access to Medicines in Egypt; Dina Iskander -- 6. The Pharmaceutical Industry in India after TRIPS; Sudip Chaudhuri -- 7. The Health Care System and the Pharmaceutical Industry in Indonesia; Richard Husada and Raymond R. Tjandrawinata -- 8. TRIPS, Free Trade Agreements and the Pharmaceutical Industry in Malaysia; Mohamed Azmi Hassali, Jayabalan Thambyappa, Shankaran Nambiar and Asrul Akmal Shafie -- 9. The Pharmaceutical Industry, Intellectual Property Rights and Access to Medicines in Pakistan: Zaheer-Ud-Din Babar, Shazia Jamshed, Ashar Malik and Anwarul-Hassan Gilani -- 10. TRIPS, Access to Medicines and Local Production in South Africa; Andrew L. Gray and Yousuf A. Vawda -- 11. TRIPS and New Challenges for the Pharmaceutical Sector in South Korea; Bong-min Yang and Hye-young Kwon -- 12. Intellectual Property Rights and Neoliberal Restructuring in Turkey: The Pharmaceutical Industry; Ipek Eren Vural -- 13. Conclusion: TRIPS, Drug Production in the Global South, and Access to Medicines; Hans Löfgren and Owain David Williams.
Some two decades will shortly have passed since the WTO's Trade Related Aspects of Intellectual Property Rights agreement came into force in 1995. This volume is the first cross-country analysis of how TRIPS has affected the capacity of 11 major low or medium income countries to produce generic drugs.
Political economy.
Economic policy.
Economic development.
International relations.
Social medicine.
Development economics.
International Political Economy.
Economic Policy.
Development Studies.
International Relations.
Medical Sociology.
Development Economics.